The Division of Clinical Immunology and Allergy’s research programs involve many areas of clinical immunology and allergy.
Our faculty members have identified PAF acetylhydrolase deficiency, which predisposes to severe life-threatening and fatal anaphylactic reactions and as a result, a new rapid drug desensitization program for the induction of immunologic tolerance makes possible the use of medication in patients with previous severe reactions.
Our faculty members have developed research with novel desensitization techniques for milk and peanut anaphylaxis, and expertise in primary immune deficiency and gammaglobulin replacement treatment. Our divisional faculty members are leading an international collaborative team examining the role of sequestered auto-antigens in inducible forms of physical urticaria (ie: cholinergic, exercise, and cold-induced urticaria).
Innovative research discoveries, when put into practice in a clinical setting, allow patients with lifelong debilitating diseases to receive the treatment they need to live normal lives. We will continue to expand new knowledge and research areas of all aspects of immunologic and allergic diseases.
